Pharma CF

Zyden Gentec Ltd.
CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Mar-14 Mar-13 Mar-12 Mar-11
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Interest Paid
Tax Paid
Other Direct Expenses paid
Extra & Other Item
Cash From Operating Activities
Cash Flow from Investing Activities
Cash from Financing Activities
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Cash & Cash Equivalent of Subsidiaries under liquidations
Translation adj. on reserves / op cash balances frgn subsidiaries
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
-0.26
-1.03
1.55
0.26
-0.73
-0.27
4.69
3.69
-4.46
1.54
1.15
-1.78
-0.02
1.12
-2.67
-1.58
-0.03
0.26
1.34
-1.69
-0.09
0.12
3.69
0.35
-4.03
0.01
0.11
-1.78
-6.44
8.08
-0.14
0.25
-1.61
-4.25
5.91
0.05
0.20
0.03
0.12
0.11
0.25
Source:AceEquity
Disclaimer : Accord Fintech Pvt Ltd has taken all the necessary steps and measures in compilation of the Data present in the
or omissions or for the results obtained from the use of such Data. Accord Fintech especially states that it has no financial lia
generated from the AceEquity.
Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04 Mar-03 Mar-02 Mar-01 Mar-00 Mar-99
0.20
1.07
2.74
4.01
0.11
1.36
-4.12
-2.65
0.42
0.45
-2.86
-1.98
0.14
0.10
0.20
0.45
0.70
-0.26
-1.50
-1.05
0.24
-0.23
0.22
0.23
0.55
-0.49
0.08
0.14
0.10
-0.04
0.08
0.15
0.02
0.08
-0.10
0.00
-0.02
-0.01
-0.06
-0.02
-0.01
-0.01
3.98
-4.68
0.85
0.16
0.04
-2.71
0.28
2.42
-0.01
0.05
-0.01
-2.02
0.17
1.81
-0.04
0.09
0.00
0.43
-1.11
0.52
-0.16
0.25
-1.06
-1.48
2.26
-0.28
0.53
0.23
-0.70
0.99
0.52
0.01
0.14
0.21
-0.34
0.00
0.01
0.15
-0.53
0.38
0.00
0.01
0.00
0.20
0.04
0.05
0.09
0.25
0.53
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.29
-0.02
-0.19
0.08
-0.02
0.01
0.01
0.00
-0.10
-0.01
0.00
0.00
0.00
-0.02
0.02
0.00
0.02
0.00
0.02
of the Data present in the AceEquity. We have tried our level best to provide data from reliable source. However, Accord Fintech Pvt Ltd
es that it has no financial liability whatsoever to the users of AceEquity.Accord or any of its directors/ employees/ representatives does no
Mar-98
-1.56
1.45
-0.01
-0.12
0.00
-0.12
0.13
0.01
0.01
0.02
wever, Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or completeness of any Data in the AceEquity and is not respon
yees/ representatives does not accept any liability for any direct or consequential loss arising from the use of the Data contained in the A
eEquity and is not responsible for any errors

e Data contained in the AceEquity or any data
Venus Remedies Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
65.73
35.95
-49.12
52.56
62.67
39.38
-51.39
50.66
55.15
27.76
-44.85
38.06
54.76
23.16
-38.58
39.34
52.56 50.66
-93.75 -102.47
39.31 55.15
-1.88
3.35
6.26
2.91
38.06
-93.63
55.57
0.00
2.91
39.34
-98.23
59.80
0.91
2.00
2.91
2.91
4.38
6.26
Source:AceEquity
any errors or omissions or for the results obtained from the use of such Data. Accord Fintech especially states that it has no f
AceEquity or any data generated from the AceEquity.
48.95
11.62
-25.33
35.25
49.26
7.18
-35.50
20.94
46.04
5.91
-30.72
21.23
33.41
4.13
-10.60
26.95
18.33
2.47
-11.91
8.90
-0.02
4.76
1.22
0.28
6.26
1.50
0.81
-0.70
1.62
0.58
0.76
-1.00
0.34
-0.04
-0.01
-0.02
0.84
0.67
-1.08
0.43
0.90
0.56
-1.21
0.24
0.57
0.87
-1.38
0.05
0.15
0.84
0.04
1.03
-0.08
-0.07
-0.02
-0.02
1.00
-0.59
-0.35
0.05
0.12
0.17
35.25
-52.35
17.81
0.71
1.29
20.94
-56.56
35.87
0.24
1.05
21.23
-33.78
10.69
-1.86
2.92
26.93
-87.99
63.42
2.36
0.56
8.90
-24.93
15.23
-0.80
1.36
6.22
-7.33
1.90
0.79
0.58
1.61
-0.87
-0.57
0.17
0.40
0.33
-0.85
0.43
-0.09
0.49
0.43
-0.74
0.48
0.18
0.32
0.16
-1.16
1.07
0.07
0.24
-0.03
-0.05
-0.55
0.67
0.07
0.17
2.00
1.29
1.05
2.92
0.56
1.36
0.58
0.40
0.49
0.32
0.24
ecially states that it has no financial liability whatsoever to the users of AceEquity.Accord or any of its directors/ employees/ representati
ors/ employees/ representatives does not accept any liability for any direct or consequential loss arising from the use of the Data contain
n the AceEquity and is not responsible for

g from the use of the Data contained in the
Sun Pharmaceutical Industries Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Mar-14 Mar-13 Mar-12
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
Mar-11
-2801.09 663.03 1725.83 1453.98

43.19 -73.57 112.03 -114.31
501.61 -314.22 -354.25
-32.30
-2256.29 275.24 1483.61 1307.37
-148.77 -168.76 -144.43
-2405.06
519.14
1742.10
-143.82
221.81
-73.57
106.48 1339.18 1233.80

460.54 -773.69 -1073.15
-508.99 -420.21 -311.58
58.03 145.28 -150.93
168.72
20.38 173.25
-1.67
-4.94
76.32 221.81
3.06
168.72
-1.94
20.38
Source:AceEquity
from the use of such Data. Accord Fintech especially states that it has no financial liability whatsoever to the users of AceEqu
949.16 1295.41 1052.20
26.58 -141.34 -19.71
-280.95 107.53 -359.94
694.79 1261.60 672.55
-48.79
0.89
-46.42
640.54 488.68 323.48 294.01 252.83 187.28 144.63

-96.92 -59.05
23.32 17.03 12.45 14.53 14.28
-77.60 -103.47 -117.08 33.28 -87.84 -37.16 -99.63
466.02 326.16 229.72 344.32 177.44 164.65 59.28
0.95
-15.46 -15.35
-9.91 -14.37 -16.71 -14.57 -10.25
97.18
17.82
-23.15
91.85
-0.97
-5.36
60.99
15.92
-39.83
37.08
-4.93
-3.06
28.74
78.72
-36.22
-36.29
6.21
4.35
-11.85
73.67
-28.86
-48.96
-4.15
8.50
0.35
29.44
-77.91
50.60
2.13
6.37
10.56
4.35
8.50
646.00 1262.49 626.13 450.56 310.81 219.81 329.95 160.73 150.08

-158.76 -951.07 -743.49 -112.58 160.76 -863.44 -531.70 -64.33 -41.81
-327.34 -325.67
-6.06 -360.48 -130.62 1457.89 198.80 -42.31 -103.55
159.90 -14.25 -123.42 -22.50 340.95 814.26
-2.95 54.09
4.72
48.01
62.26 1100.73 1230.98 890.03
75.75 78.68 24.61 19.89
0.02
0.02
207.91
48.01
977.31 1208.48 1230.98
890.03
75.75
78.70
24.61
the Data present in the AceEquity. We have tried our level best to provide data from reliable source. However, Accord Fintech Pvt Ltd do
r to the users of AceEquity.Accord or any of its directors/ employees/ representatives does not accept any liability for any direct or conse
Mar-98 Mar-97 Mar-96 Mar-95 Mar-94

57.13
6.34
-23.75
39.73
1.11
-0.77
50.67
10.66
4.78
66.11
-5.40
-1.60
36.98
7.89
-24.40
20.47
-4.66
36.98
7.89
-24.40
20.47
-4.66
4.68
44.75
-63.55
21.95
3.14
3.24
59.11
-46.74
-11.76
0.60
2.63
15.81
-24.76
6.31
-2.64
5.27
15.81
-24.76
6.31
-2.64
5.27
6.37
3.24
2.63
2.63
0.00
0.00
0.00
Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or completeness of any Data in the AceEquity and is not responsible fo
ity for any direct or consequential loss arising from the use of the Data contained in the AceEquity or any data generated from the AceE
AceEquity and is not responsible for any errors or omissions or for the results obtained
any data generated from the AceEquity.
Sandu Pharmaceuticals Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
0.82
1.26
-2.91
-0.82
1.16
0.86
3.06
5.08
1.12
0.72
-1.24
0.59
1.06
0.67
-0.29
1.45
-0.24
-0.41
-0.28
-0.25
-1.06
-0.70
-0.25
-2.01
3.47
4.67
-2.11
-0.07
2.50
0.97
0.32
-0.51
-0.28
-0.47
1.44
1.20
-0.46
-0.69
0.05
1.39
1.46
3.47
0.97
1.44
Source:AceEquity
0.87
0.72
-0.03
1.56
-0.35
-0.19
0.90
0.73
-1.08
0.56
-0.38
-0.07
0.80
0.43
-0.73
0.50
-0.33
-0.10
0.03
1.06
-0.30
0.50
1.26
0.13
0.11
-0.20
0.12
0.02
0.11
-0.03
0.04
-0.27
0.14
-0.10
0.21
1.39
0.13
0.11
1.20
0.60
-1.52
0.27
-0.27
-0.10
0.00
-0.09
-0.01
0.13
0.02
0.18
0.00
0.00
0.00
0.00
0.21
1.10
0.59
-1.18
0.51
-0.27
-0.07
0.02
0.80
0.62
-1.43
-0.01
-0.31
-0.06
0.79
0.67
-0.59
0.87
-0.34
0.18
-0.03
-0.35
-0.20
0.38
0.00
-0.38
-0.06
0.44
0.00
0.38
0.00
0.53
-0.21
0.03
0.34
0.04
0.18
0.38
0.38
0.70
0.67
-0.89
0.49
-0.35
0.61
0.66
-0.53
0.74
-0.38
0.54
0.58
-0.61
0.51
-0.38
0.52
0.45
-0.69
0.28
-0.31
0.26
0.26
-0.27
0.24
-0.22
-0.03
0.15
-0.23
0.08
-0.01
0.05
0.00
0.36
-0.22
-0.15
-0.01
0.06
0.13
-0.35
0.23
0.01
0.05
0.00
-0.03
-0.15
0.21
0.03
0.02
-0.01
-0.31
0.29
-0.02
0.04
0.04
0.05
0.06
0.05
0.02
Mar-98
0.00
0.05
0.35
0.40
-0.14
0.26
-0.46
0.22
0.02
0.02
0.04

Pfizer Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item

339.59
-87.82
4.62
256.39
279.65 277.90 347.65

-84.49 -69.40 -65.23
-2.91 -61.86 -50.26
192.25 146.65 232.16
-123.94 -208.26 -121.81 -148.99
132.45
102.66
-1360.17
-1125.06
1432.92
-16.01
625.87
-43.20
566.66
866.26
-0.38
-3.03
24.46 80.14
277.52 57.14
-14.13 -86.26
287.85 51.01
578.42 527.40
307.86 1432.92 866.26 578.42
Source:AceEquity
omissions or for the results obtained from the use of such Data. Accord Fintech especially states that it has no financial liabili
Nov-09 Nov-08 Nov-07 Nov-06 Nov-05 Nov-04 Nov-03 Nov-02 Nov-01 Nov-00 Nov-99 Nov-98
220.93 210.66 467.48 185.38 132.61 94.06 63.05 111.64
-45.01 -49.94 -298.21
-8.44 10.32
9.18
7.00
3.22
12.99
-7.53 -32.40 12.24
-2.81
7.51 54.44 -36.31
188.91 153.19 136.87 189.18 140.12 110.75 124.49 78.56
-103.32 -126.73 -112.97
62.72
8.84
-1.26
70.30
-28.98
52.23
12.97
-21.66
43.54
-0.49
-16.08
18.87
11.50
22.24
52.61
-1.99
-13.61
-30.95
26.97
-15.19
-5.17
6.61
6.64
37.00
-7.76
-24.12
5.12
1.52
13.25
6.64
-37.32
-10.51
-48.25
-48.54
-10.92 210.84
-6.95
74.67 237.30 16.95 122.97 102.80
-47.55 -78.87 232.35 -47.99 -73.08
-43.32 -95.20 -75.90 -33.82 -46.02
-16.20 63.23 173.40 41.16 -16.30
543.02 479.79 306.39
9.78 26.07
0.59
-12.96
87.28
-68.50
-14.71
4.07
21.52
0.48
-16.18
60.06
-72.43
-24.39
-36.76
58.28
-60.10
-30.08
54.51
-17.61
6.82
20.31
31.14
28.57
-27.65
-11.60
-10.68
31.00
-6.00
35.32
-10.67
-6.91
17.75
13.25
26.07
21.52
58.28
20.31
31.00
527.40 543.02 479.79
-66.21
77.02
5.59
-23.09
59.52
50.94
9.78
the Data present in the AceEquity. We have tried our level best to provide data from reliable source. However, Accord Fintech Pvt Ltd d
at it has no financial liability whatsoever to the users of AceEquity.Accord or any of its directors/ employees/ representatives does not acc
Nov-97
20.59
8.63
-8.74
20.49
-1.72
-8.16
10.61
-14.47
7.53
3.66
-2.14
1.52
er, Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or completeness of any Data in the AceEquity and is not responsible
epresentatives does not accept any liability for any direct or consequential loss arising from the use of the Data contained in the AceEqui
ity and is not responsible for any errors or

contained in the AceEquity or any data
Nutraplus India Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
5.11
5.10
-7.52
2.68
3.80
3.56
-4.05
3.31
4.27
2.30
0.76
7.33
3.31
1.77
-1.26
3.82
1.28
0.02
0.03
0.16
0.24
3.98
-10.82
6.80
-0.04
1.47
3.50
-8.50
5.10
0.11
1.37
7.57
-10.59
3.12
0.10
1.26
-0.43
-0.36
-0.21
2.83
-2.61
0.92
1.14
0.12
1.43
1.47
1.37
1.25
Source:AceEquity
1.15
1.18
-2.35
-0.01
0.57
0.78
0.67
2.02
0.42
0.52
-0.60
0.34
0.27
0.63
-0.96
-0.06
-0.05
-0.02
0.00
-0.05
-0.04
-0.23
0.22
0.34
0.31
0.87
-0.02
0.21
0.03
-1.35
-1.12
-0.02
0.25
-0.02
-0.34
-0.11
-0.02
0.14
-0.17
0.52
0.49
0.20
-0.21
-0.02
-0.02
1.13
-1.43
0.31
0.01
-0.01
-0.15
-0.12
0.00
-1.46
-1.63
2.86
-0.81
0.42
0.11
-0.08
-3.36
3.25
-0.19
0.31
2.02
-2.44
0.59
0.17
0.14
0.28
-1.63
-1.82
-3.17
3.32
-0.32
-0.40
0.82
0.10
3.21
0.85
0.08
-0.94
-0.01
3.22
-1.13
-0.35
1.64
0.15
3.07
-0.13
-1.32
1.39
-0.05
3.12
0.48
-0.58
0.06
-0.04
3.15
-0.17
0.25
-0.07
0.00
3.15
-0.12
1.49
0.59
1.96
1.19
0.12
0.31
0.14
3.32
3.21
3.22
3.07
3.12
3.15
3.15
0.00
0.00
0.00
1.48
0.02
-1.67
-0.17
0.54
Mar-98
0.40
0.35
-0.43
0.32
0.32
-0.25
0.04
0.11
0.00
0.11

Novartis India Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
89.90 169.42 224.69 218.91

-77.76 -70.96 -69.55 -50.13
16.42 -30.41
5.02
-7.56
28.56 68.05 160.16 161.22
-30.78
-60.62
-85.44
-70.67
-2.22
19.82
-37.79
-20.19
35.54
7.43
-16.06
-37.33
-45.96
81.50
74.72
-42.71
-37.49
-5.48
86.98
90.55
-21.76
-37.51
31.28
57.00
15.35
35.54
81.50
88.28
Source:AceEquity
the results obtained from the use of such Data. Accord Fintech especially states that it has no financial liability whatsoever to
179.80 172.91 154.31 135.35 148.92 104.04 117.95
-29.65 -38.05 -31.25 -31.65 -34.39 -20.41 -17.61
8.54 27.23
1.84
0.69 -20.74 31.27 -23.53
158.69 162.09 124.90 104.39 93.79 114.90 76.81
83.90
-10.36
8.07
81.61
92.07
-9.70
-6.80
75.57
-61.22
-68.56
-58.78
-53.66
-32.51
-34.69
-30.85
-26.63
-26.95
97.47
-56.43
-37.60
3.44
53.75
93.52
-16.78
-38.19
38.55
15.20
66.12 50.73
-47.39 -81.83
-8.84 -89.45
9.89 -120.55
5.31 125.86
61.28
39.06
-39.22
61.12
64.75
-0.01
80.21
12.46
-36.59
56.08
8.66
45.95
-51.02
-31.17
-36.23
44.89
54.98 48.62
-1.92 15.52
-26.32 -115.38
26.74 -51.24
18.15 69.40
57.19
53.75
5.31 125.86
64.75
8.66
15.20
44.89
18.15
61.23 160.26 111.64

12.75
-0.70 15.53
7.43
4.86 -16.25
81.41 164.41 110.93
-4.82
-21.92 -59.19 -63.67
59.49 105.22
23.43 -14.03
-71.39 -44.42
11.53 46.77
57.70 10.93
0.16
69.40
57.70
42.43
-27.91
-13.73
0.79
10.14
10.93
ncial liability whatsoever to the users of AceEquity.Accord or any of its directors/ employees/ representatives does not accept any liabilit

65.67
22.33
21.25
109.24
-9.80
-19.46
35.37
23.08
-24.59
33.86
-17.02
-1.98
47.11
13.73
-59.42
1.41
-7.01
-25.91
79.98
-9.96
-64.14
5.88
4.27
14.86
-4.83
-15.84
-5.81
8.19
1.89
-31.50
-6.90
29.64
-8.76
16.94
10.14
4.27
8.19
es does not accept any liability for any direct or consequential loss arising from the use of the Data contained in the AceEquity or any data
e AceEquity and is not responsible for any errors or omissions or for

d in the AceEquity or any data generated from the AceEquity.
Medicamen Biotech Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
0.09
4.52
0.53
5.14
-4.93
4.01
-0.65
-1.57
-0.82
3.44
-4.79
-2.17
2.78
4.60
5.53
12.90
-1.32
-1.55
5.14
-0.84
-3.68
0.62
2.09
-1.57
-1.05
1.80
-0.81
2.91
-3.49
-1.49
3.08
-1.90
4.81
11.35
-3.81
-3.97
3.57
1.24
2.71
2.09
2.91
4.81
Source:AceEquity
3.98
4.26
-6.62
1.61
1.38
2.80
4.35
8.53
1.51
2.44
-0.15
3.80
1.51
1.32
-1.91
0.92
1.49
1.36
0.43
3.28
1.41
1.33
-1.05
1.69
0.46
1.16
-1.04
0.58
0.19
1.04
3.91
5.13
0.26
2.21
-2.99
-0.52
-1.02
1.87
0.12
0.98
-0.40
1.81
-1.73
-0.32
-1.42
1.90
0.12
0.61
-0.51
-0.22
1.10
-3.46
2.71
0.35
0.89
8.31
-2.00
-6.08
0.22
0.67
3.80
-3.19
-0.40
0.20
0.47
0.92
-5.02
4.37
0.28
0.19
3.28
-1.94
-2.33
-0.99
1.18
1.69
0.19
-1.79
0.09
1.09
0.58
-0.63
-1.18
-1.23
2.32
5.13
0.65
-3.95
1.84
0.48
-0.52
-0.59
1.09
-0.02
0.50
0.98
-0.17
-0.76
0.05
0.45
-0.32
-0.63
0.77
-0.18
0.63
0.61
-0.46
-0.04
0.11
0.52
1.24
0.89
0.67
0.47
0.19
1.18
1.09
2.32
0.48
0.50
0.45
0.63
Mar-98
-1.38
1.57
0.75
0.94
0.94
-0.55
-0.12
0.27
0.25
0.52

Jenburkt Pharmaceuticals Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
10.33
1.45
2.42
14.20
-1.27
-2.83
8.82
1.38
-2.21
7.99
-0.94
-2.57
8.52
1.07
0.25
9.84
-0.63
-2.42
9.09
1.20
0.46
10.75
-0.52
-2.90
0.08
10.18
0.45
-5.29
5.34
11.41
0.06
4.54
-1.15
0.08
3.48
7.93
0.14
6.92
-2.84
-1.66
2.42
5.51
7.33
-3.22
-2.19
1.92
3.59
16.75
11.41
7.93
5.51
Source:AceEquity
5.73
1.04
1.76
8.53
-0.53
-1.77
2.90
1.22
2.95
7.07
-0.85
-0.80
2.16
1.20
-1.34
2.01
-0.98
-0.40
-0.10
-1.49
4.74
-0.59
-3.71
0.44
3.15
-0.99
4.43
-0.97
-3.56
-0.10
3.25
0.54
-0.18
-0.15
0.20
3.04
3.59
3.15
3.25
2.03
1.12
-0.47
2.68
-0.86
-0.28
-0.13
1.67
-0.02
0.73
2.38
-0.69
-0.39
1.15
0.56
0.04
1.74
-0.67
-0.07
0.96
0.60
-0.68
0.87
-0.65
-0.08
0.72
0.44
-0.44
0.72
-0.60
-0.08
0.70
0.21
0.02
0.94
-0.48
-0.06
0.19
0.05
-0.16
0.08
-0.40
-0.22
0.81
0.49
0.54
1.84
-0.29
-0.17
0.38
0.47
-0.65
0.20
-0.26
-0.01
1.41
-1.60
-0.06
-0.26
3.30
-0.30
1.00
-0.16
-0.68
0.17
3.13
0.03
1.03
-1.38
0.01
-0.34
3.47
0.03
0.17
-0.56
0.76
0.36
3.10
0.10
0.15
-0.77
0.44
-0.18
3.28
0.16
0.56
-0.16
-0.15
0.25
3.03
0.05
-0.48
0.44
0.39
0.36
2.67
0.02
1.40
-0.21
0.12
1.31
1.36
0.01
-0.07
-0.25
0.71
0.39
0.97
3.04
3.30
3.13
3.47
3.10
3.28
3.03
2.67
1.36
Mar-98
0.08
0.54
-0.39
0.23
-0.26
0.00
0.00
-0.03
-0.15
0.51
0.32
0.64
0.97

JB Chemicals && Pharmaceuticals Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
93.99 107.74 809.22 141.05

14.11
-6.43
3.51 23.67
-93.19
0.67 202.58
1.62
14.90 101.98 1015.31 166.34
-26.55
-21.57 -164.51
-29.51
-11.65 80.41 850.80 136.83

-138.77 -111.73 -235.86 -89.41
12.12 -30.93 -526.49
4.93
-138.31 -62.25
88.44 52.35
149.11 211.36 122.92 70.57
10.80 149.11
211.36 122.92
Source:AceEquity
120.94 91.78
20.94 59.46
-11.76 -42.01
130.12 109.24
-20.98
-10.74
109.15
-29.35
-50.68
29.11
41.45
98.50
-16.68
-54.87
26.95
14.51
70.57
41.45
49.11
37.69
-41.02
45.77
0.00
-7.62
0.00
79.77
21.24
-60.79
40.22
0.00
-4.75
0.00
83.32
10.89
-63.09
31.12
67.03
6.81
-44.11
29.73
65.19
10.30
-26.98
48.52
62.38
11.08
-26.45
47.00
53.51
16.08
-16.66
52.93
-13.99
39.49
10.34
-23.05
26.78
-2.18
-6.76
22.03
7.41
-6.71
22.74
-3.25
-0.17
14.54
7.82
-5.31
17.05
-4.15
-0.29
-8.78
-7.23
-13.57
-13.31
38.15 35.47
-37.35 -114.73
-6.00 87.39
-5.20
8.12
19.71 11.59
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
14.51 19.71
22.34
-22.57
2.39
2.17
9.22
22.50
-17.33
-1.54
3.62
5.60
34.95
-41.94
3.14
-3.86
9.46
33.69
-20.47
-10.72
2.50
6.96
38.94
-29.07
-9.14
0.73
6.22
17.84
-6.30
-13.36
-1.82
8.04
19.32
-1.09
-16.12
2.11
5.76
12.60
-3.28
-9.68
-0.35
6.11
11.39
9.22
5.60
9.46
6.96
6.22
7.87
5.76
cial liability whatsoever to the users of AceEquity.Accord or any of its directors/ employees/ representatives does not accept any liability

27.50
5.89
-11.98
21.41
-4.79
-0.15
20.89
6.71
-13.66
13.94
-6.56
0.40
12.82
7.54
-13.60
6.77
-5.07
-0.22
16.48
-15.69
1.08
1.86
4.25
7.78
-4.09
-2.94
0.74
3.51
1.48
-10.23
10.88
2.13
1.38
6.11
4.25
3.51
wever, Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or completeness of any Data in the AceEquity and is not respons
s does not accept any liability for any direct or consequential loss arising from the use of the Data contained in the AceEquity or any data
e AceEquity and is not responsible for any errors or omissions or for

Ipca Laboratories Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
629.09
133.00
-104.82
657.27
461.37
117.23
-100.02
478.58
-130.19
-91.73
368.94 343.70
152.12 37.06
-122.32 -102.16
398.74 278.60
-79.90
-64.03
527.08 386.85 318.84 214.57

-374.37 -260.92 -251.45 -198.84
-138.36 -80.63 -69.02 -16.80
14.35 45.30
-1.63
-1.07
53.11
7.81
7.22
8.29
2.22
67.46
53.11
7.81
7.22
Source:AceEquity
271.73 124.65 176.87 150.40 78.39 101.55 108.01
65.76 143.92
9.57 37.42 41.66 25.03
2.01
-97.55 -90.06 -46.05 -50.68 12.49 -47.69 -23.84
239.94 178.51 140.39 137.14 132.54 78.89 86.17
79.32
12.84
-18.29
73.86
42.95
28.28
-17.35
53.89
22.09
25.29
-21.64
25.74
-45.44
-0.98
-18.34
-15.42
0.63
-1.59
-22.41
-1.18
-29.02
-1.06
-23.67
-0.22
-8.69
-17.21
193.52 154.92 110.31 113.25 123.85 61.68

-126.60 -105.96 -145.30 -90.82 -77.89 -118.74
-64.47 -50.71 37.01 -20.53 -46.46 56.24
2.45
-1.75
2.02
1.90
-0.50
-0.83
5.84
7.59
5.57
3.67
4.17
4.77
0.22
8.29
5.84
7.59
5.57
3.67
4.17
-10.30
26.92
23.84
15.37
66.13
-16.09
-1.61
25.44
22.79
-17.45
30.79
-16.79
-0.65
75.88
-66.73
-6.82
2.33
2.44
55.52
-23.60
-32.62
-0.70
3.14
39.10
-10.22
-30.41
-1.53
4.67
24.15
-29.71
6.21
0.65
4.31
48.44
-26.82
-20.10
1.51
2.79
-3.42
9.92
-19.46
8.92
-0.62
3.41
4.77
2.44
3.14
4.96
4.31
2.79
cial liability whatsoever to the users of AceEquity.Accord or any of its directors/ employees/ representatives does not accept any liability

19.40
16.80
0.73
36.94
-12.41
-0.28
18.21
15.70
-14.02
19.89
-11.42
-0.68
24.25
-14.78
-7.55
1.92
1.49
7.78
-15.86
8.42
0.34
1.14
3.41
1.49
0.00
0.00
0.00
ever, Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or completeness of any Data in the AceEquity and is not respons
s does not accept any liability for any direct or consequential loss arising from the use of the Data contained in the AceEquity or any data
AceEquity and is not responsible for any errors or omissions or for

Hester Biosciences Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
14.29
11.60
-5.85
20.04
15.03
7.45
-3.56
18.92
12.20
6.77
-5.58
13.40
11.18
6.91
-8.00
10.09
-9.86
-5.50
-0.73
-2.49
10.17
-12.78
2.54
-0.06
0.75
13.42
-17.52
3.94
-0.16
0.90
12.67
-7.36
-5.03
0.27
0.63
7.61
-6.21
-1.45
-0.05
0.96
0.69
0.75
0.90
0.91
Source:AceEquity
any errors or omissions or for the results obtained from the use of such Data. Accord Fintech especially states that it has no f
9.60
6.51
-0.12
16.00
11.04
3.75
-4.13
10.66
-2.89
13.56
3.57
-4.62
12.51
-2.65
8.63
0.18
9.66
18.47
-0.70
8.61
-1.15
-2.47
4.99
-0.26
6.59
0.35
-4.63
2.30
-0.24
2.21
0.28
-1.15
1.34
-0.26
0.94
0.18
-0.39
0.73
-0.27
0.58
0.34
-0.65
0.27
-0.15
0.58
0.34
-0.34
0.59
-0.18
-0.15
0.31
-0.79
-0.63
-0.08
0.32
-0.02
0.22
-0.47
16.00
-3.46
-12.23
0.31
0.65
7.77
-3.38
-4.40
0.00
0.65
9.85
-9.04
-7.06
-6.25
6.90
17.78
-28.56
17.51
6.73
0.17
4.74
-2.83
-2.71
-0.80
0.98
2.06
-0.80
-0.32
0.93
0.04
1.08
-0.34
-0.72
0.03
0.02
0.46
-0.03
-0.42
0.00
0.01
0.12
-0.06
-0.14
-0.08
0.10
0.41
-0.36
-0.02
0.03
0.07
-0.63
0.00
0.67
0.03
0.03
-0.24
-0.02
0.29
0.02
0.01
0.96
0.65
0.65
6.90
0.17
0.98
0.04
0.02
0.01
0.10
0.07
0.03
ecially states that it has no financial liability whatsoever to the users of AceEquity.Accord or any of its directors/ employees/ representati
ors/ employees/ representatives does not accept any liability for any direct or consequential loss arising from the use of the Data contain
n the AceEquity and is not responsible for

g from the use of the Data contained in the
Glenmark Pharmaceuticals Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
501.92 379.95 284.10 250.79

140.11 25.60 14.80 35.24
-450.65 -84.99 -58.24 182.72
191.39 320.57 240.66 468.75
-77.15
-67.55
-46.01
-47.69
114.24 253.02 194.65 421.06

216.55 -113.26 601.53 -654.72
-384.66 -13.77 -779.73 259.40
-53.88 125.99 16.46 25.74
165.44 45.49 29.03
3.29
-5.80
-6.05
105.76 165.44
45.49
29.03
Source:AceEquity
errors or omissions or for the results obtained from the use of such Data. Accord Fintech especially states that it has no finan
121.01 246.07 431.19 170.82 85.30
176.72
7.21 57.69 51.83 26.03
721.72 -114.51 -186.94 -212.85 -124.27
1019.45 138.77 301.93
9.80 -12.93
-36.29
-44.71
-55.27
-18.62
-12.56
86.94
34.32
-89.71
31.54
52.54
22.29
-44.76
30.07
43.52
26.65
-56.11
14.06
28.48
25.32
-18.94
34.85
18.61
12.91
-26.71
4.81
28.67
-13.11
-19.66
-4.10
12.77
1.33
-10.50
3.61
-21.43
-6.23
-4.74
-2.24
-2.30
-6.99
-3.66
983.17 94.06 246.67

-8.83 -25.49 10.11
-1000.22 -589.14 -15.70 -237.92 -239.08 -203.87
10.45 495.62 -231.18 168.98 244.45 296.27
-6.61
0.53
-0.21 -77.77 -20.12 102.51
11.69 11.18 11.39 89.16 109.28
6.77
23.84
-42.59
21.48
2.72
4.05
9.33
-39.18
29.37
-0.48
4.53
32.61
-23.47
-11.78
-2.64
7.17
2.51
-91.29
65.53
-23.25
30.42
-11.09
-4.29
43.70
28.32
2.11
-0.01
-0.06
0.78
-1.34
-0.61
2.72
6.77
4.05
4.53
7.17
30.42
2.11
-0.02
5.08
11.69
11.18
11.39
89.16 109.28
y states that it has no financial liability whatsoever to the users of AceEquity.Accord or any of its directors/ employees/ representatives d
ver, Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or completeness of any Data in the AceEquity and is not responsib
mployees/ representatives does not accept any liability for any direct or consequential loss arising from the use of the Data contained in t
he AceEquity and is not responsible for any

the use of the Data contained in the
Cadila Healthcare Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
945.70
-81.70
-49.60
814.40
22.10
25.90
862.40
-392.00
-445.50
24.90
104.50
531.40 670.40 637.20

134.90 -47.40 97.00
-161.30 -229.70 -111.30
505.00 393.30 622.90
-68.30
-23.20
-63.40
8.50
1.60
445.20 371.70 559.50
-755.20 -817.40 -367.60
250.20 521.60 -177.70
-59.80 75.90 14.20
118.30 42.40 28.20
46.00
129.40 104.50 118.30
42.40
Source:AceEquity
520.30 296.40 278.50 231.90 199.90 162.80 175.90 114.30 73.40
102.00 94.40 69.80 33.10 41.60 31.40 12.00 60.50 19.70
-39.70
-7.10 -258.20 -18.30 -154.20 -40.20
7.80 36.60 -171.10
582.60 383.70 90.10 246.70 87.30 154.00 195.70 211.40 -78.00
-65.00 -37.40 -26.80 -20.10 -19.60 -20.90 -37.10 -14.10
-25.60 -22.80 -13.90 -20.90 -14.80 -10.90
-8.80 -10.00
-4.40
29.20 -27.70
2.70 11.60
586.20 268.20 41.50 210.60
-248.60 -261.10 -267.40 -172.10
-335.00
5.80 232.50 -28.40
2.60 12.90
6.60 10.10
25.60 19.00 12.40
2.30
-6.30
0.00
0.00
28.20
25.60
19.00
12.40
45.23
28.36
-29.32
44.27
-17.45
-6.77
36.25
14.38
-6.34
44.29
-6.69
-2.87
3.30
-1.40
0.20 -25.70
9.40 12.73
2.58
55.70 122.10 166.20 138.60 -87.10 44.29 22.63
-98.50 -56.30 -76.60 -178.30 -144.20 -188.66 -97.16
18.70 -76.60 -62.20
-1.60 195.00 -192.42 446.35
-24.10 -10.80 27.40 -41.30 -36.30 -336.79 371.82
26.40 37.20
8.90
5.60 41.90 378.66
6.84
0.00
0.00
0.90 44.80
1.66
36.40
-78.84
45.21
2.78
4.06
2.30
26.40
37.20
9.10
5.60
70.81
11.17
-30.15
51.83
-14.27
-6.00
41.87 378.66
6.84
ever, Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or completeness of any Data in the AceEquity and is not responsi
mployees/ representatives does not accept any liability for any direct or consequential loss arising from the use of the Data contained in
the AceEquity and is not responsible for any

the use of the Data contained in the
Biocon Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item

408.60 347.00 304.40 517.20
80.20 69.10 56.80 53.80
-210.00
2.90 -142.60 -165.40
278.80 419.00 218.60 405.60
-93.00
-71.00
-58.10
-50.90
185.80 348.00 160.50 354.70

46.10 -87.10 -196.20 -150.40
-187.00 -147.10 -111.30 -99.80
44.90 113.80 -147.00 104.50
154.00 39.80 185.30 77.10
0.50
4.60
0.40
204.00 154.00
1.50
3.70
39.80 185.30
Source:AceEquity
and is not responsible for any errors or omissions or for the results obtained from the use of such Data. Accord Fintech espec
arising from the use of the Data contained in the AceEquity or any data generated from the AceEquity.
Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04 Mar-03 Mar-02

276.23 114.46 513.95 171.05 160.87 188.51 147.48
70.62 68.27 -248.69 67.45 20.82
9.38 15.73
-97.52 -61.60 13.68 -110.61 -123.13 -32.67 -37.73
249.33 121.13 278.94 127.89 58.56 165.23 125.48
0.00
-18.59
-5.14 -14.08 -11.07 -18.24
-9.92 -19.67
230.73 115.99 264.86 116.81

-120.26 -74.63 -266.16 -78.79
-37.15 -43.44
1.90 -32.42
73.33
-2.08
0.60
5.60
6.04
8.12
7.53
1.93
0.00
0.00
79.38
6.04
8.12
7.53
47.73
20.29
-20.87
47.15
27.40
9.75
-19.63
17.52
-9.16
-3.28
40.32
-48.30
4.74
-3.25
3.42
1.76
155.31 105.81
-468.01 -83.67
-1.84 294.35
-314.54 316.49
317.51
1.02
0.45
37.98
-34.40
-2.65
0.93
0.10
14.24
-38.09
23.93
0.08
0.01
1.93
3.42 317.51
1.02
0.10
Data. Accord Fintech especially states that it has no financial liability whatsoever to the users of AceEquity.Accord or any of its directors/
uity.
However, Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or completeness of any Data in the AceEquity
ty.Accord or any of its directors/ employees/ representatives does not accept any liability for any direct or consequential loss
ta in the AceEquity
or consequential loss
BDH Industries Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
3.40
1.62
0.74
5.76
-0.74
-1.15
2.48
1.68
2.48
6.64
-0.83
-0.81
1.61
1.94
6.48
10.03
-0.93
-0.46
1.03
1.81
3.80
6.63
-0.95
-0.31
3.87
-0.46
2.89
6.31
11.86
5.00
-0.54
1.31
5.78
6.09
8.64
-0.15
-3.03
5.46
0.63
5.38
-1.50
-4.04
-0.17
0.80
18.17
11.86
6.09
0.63
Source:AceEquity
0.80
1.84
-0.45
2.18
-1.07
-0.18
0.43
2.15
0.08
2.65
-1.42
-0.11
0.03
1.94
0.66
2.63
-1.25
-0.08
0.64
1.79
-3.77
-1.33
-1.13
-0.08
1.01
1.56
1.67
4.23
-0.99
-0.25
0.99
1.83
-0.76
2.06
-1.24
-0.06
0.04
2.20
1.18
3.42
-1.61
-0.01
0.75
2.39
-0.15
2.98
-1.76
-0.04
0.92
2.46
-1.25
2.12
-1.83
-0.05
1.11
2.47
-0.25
3.32
-2.07
-0.11
0.15
2.10
1.25
3.50
-1.93
-0.03
0.07
1.84
-0.02
1.89
-1.00
-0.09
0.94
-0.64
-0.08
0.21
0.59
1.12
-0.20
-0.78
0.14
0.45
1.30
-1.06
-0.65
-0.41
0.86
-2.55
-2.33
4.38
-0.50
1.35
3.00
-0.45
-2.08
0.46
0.89
0.76
-0.23
-0.39
0.15
0.74
1.80
-0.05
-1.35
0.41
0.33
1.18
-0.09
-1.77
-0.68
1.01
0.25
-0.18
0.13
0.20
0.81
1.15
-0.02
-1.13
-0.01
0.82
1.54
0.30
-1.90
-0.06
0.88
-0.90
-0.11
-1.96
1.35
-0.72
1.60
0.80
0.59
0.45
0.86
1.35
0.89
0.74
0.33
1.01
0.81
0.82
0.88
Mar-98
0.59
0.78
-0.64
0.73
-0.83
-0.08
-0.18
-3.21
4.18
0.80
0.80
1.60

Bafna Pharmaceuticals Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
2.23
18.99
-20.02
1.19
5.18
15.79
15.29
36.26
5.37
9.94
13.30
28.60
4.74
6.78
-17.09
-5.57
-0.42
-0.86
-1.05
-0.78
0.77
-7.00
-12.02
-18.25
20.72
35.40
-5.69
-11.29
18.41
2.31
27.55
-36.52
-0.51
-9.47
11.78
-6.35
-10.50
26.79
9.94
1.84
2.47
20.72
2.31
11.78
Source:AceEquity
any Data in the AceEquity and is not responsible for any errors or omissions or for the results obtained from the use of such
accept any liability for any direct or consequential loss arising from the use of the Data contained in the AceEquity or any dat
Mar-10 Mar-09 Mar-08 Mar-07 Mar-05 Mar-04

3.97
4.38
-8.44
-0.09
2.48
3.32
-19.48
-13.68
1.30
0.88
-4.16
-1.98
1.12
0.11
9.01
10.23
1.39
0.69
1.76
3.85
0.65
0.44
-2.54
-1.45
-0.50
-0.30
-0.11
-0.13
0.50
0.20
-0.59
-3.17
3.57
-0.19
2.03
-13.98
-5.54
20.36
0.84
1.19
-2.09
-6.89
8.40
-0.58
1.77
10.11
-17.05
7.63
0.68
1.08
4.35
1.72
-5.40
0.67
0.50
-1.25
0.02
1.43
0.20
0.30
1.84
2.03
1.19
1.77
1.16
0.50
ained from the use of such Data. Accord Fintech especially states that it has no financial liability whatsoever to the users of AceEquity.Acc
in the AceEquity or any data generated from the AceEquity.
er, Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or completeness of
the users of AceEquity.Accord or any of its directors/ employees/ representatives does not
Astrazeneca Pharma India Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
-10.85
17.66
6.81
-70.27
2.97
61.06
-6.24
29.25 100.95
1.79
3.07
38.58
5.16
69.62 109.18
-7.62
0.20
-30.89
-44.68
-0.81
-14.57
86.22
70.84
16.83
-6.04
-15.62
-10.33
-31.98
48.81
38.73
-33.68
-29.07
-24.03
72.84
64.50
-27.69
-29.09
7.72
65.12
87.68
16.83
48.81
72.84
Source:AceEquity
omissions or for the results obtained from the use of such Data. Accord Fintech especially states that it has no financial liabili
Dec-09 Dec-08 Dec-07 Dec-06 Dec-05 Dec-04 Dec-03 Dec-02 Dec-01 Mar-01 Mar-00 Mar-99
88.39 114.38 95.35 74.95 64.78 43.69 38.42
3.18
1.48 -2.94
0.42 -0.67
2.13
2.88
-23.39 -2.20 -17.09
6.40 -13.36 17.83 -17.08
68.18 113.66 75.32 81.78 50.75 63.64 24.23
0.61
0.67
0.47
0.24
0.98
-35.61 -32.62 -36.29 -27.16 -23.13 -14.58 -15.32
32.57 81.65 39.71 54.62 28.09

2.19
5.26 -2.70 -2.46 -4.16
-110.88 -54.14 -33.97 -11.30 -28.00
-76.12 32.77
3.03 40.85 -4.08
143.80 111.04 108.00 67.15 71.22
67.68 143.80 111.04 108.00
67.15
16.78
3.13
-5.94
13.97
0.50
-8.88
5.13
2.30
9.99
17.41
-0.04
-2.85
21.89
4.31
-10.66
15.53
-0.09
-9.43
20.83
-0.19
-2.25
18.38
-0.07
-5.89
16.71
2.10
-2.25
16.56
0.60
-6.64
49.30
-5.94
-2.20
41.15
30.07
9.89
-5.06
-2.04
2.78
27.28
5.59
-2.60
-1.50
1.49
25.79
14.52
2.39
-1.97
14.94
10.85
6.02
-7.17
-1.50
-2.66
13.51
12.42
-3.84
-3.75
4.83
8.68
10.52
-4.52
-2.25
3.75
4.93
71.22
30.07
27.28
25.79
10.85
13.51
8.68
hat it has no financial liability whatsoever to the users of AceEquity.Accord or any of its directors/ employees/ representatives does not a
Mar-98 Mar-97
17.58
2.40
-4.30
15.68
0.58
-6.16
12.03
2.32
-0.62
13.74
0.17
-5.00
10.11
-5.84
-2.02
2.25
2.68
8.90
-4.19
-1.39
3.33
-0.65
4.93
2.68
owever, Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or completeness of any Data in the AceEquity and is not respo
ees/ representatives does not accept any liability for any direct or consequential loss arising from the use of the Data contained in the Ac
AceEquity and is not responsible for any errors or

he Data contained in the AceEquity or any data
Alchemist Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item

26.49
-16.36
-256.33
-246.20
22.45
-10.13
-3.68
8.64
18.54
-3.32
-48.16
-32.93
11.18
4.16
-73.72
-58.37
-9.00
-6.12
-0.86
-3.02
2.52 -33.79
-50.06
-9.31
-1.13 100.08
-48.67 56.99
68.02 11.03
-14.84
-76.23
43.82
22.62
-9.79
20.81
-255.19
-14.86
431.34
161.29
19.35
180.64
19.35
68.02
11.03
Source:AceEquity
or any data generated from the AceEquity.
Mar-10 Mar-09 Mar-08 Jun-07 Jun-06 Jun-05 Jun-04 Jun-03 Jun-02 Jun-01 Jun-00 Jun-99 Dec-97
24.67
9.92
-4.50
30.10
-6.79
-2.69
24.33
8.60
-5.79
27.14
-7.57
-5.46
-1.73
18.89
-19.94
-0.90
-1.95
22.76
14.11
-23.16
4.80
-4.25
27.01
20.81
22.76
17.98
6.60
14.51
39.09
-5.54
-3.15
23.19 20.22 14.22

8.36
7.33
1.68
25.08 -15.33 -15.80
56.63 12.22
0.10
-6.88 -6.24 -0.84
-4.91 -4.57 -0.56
9.50
0.56
-8.50
1.56
-0.28
0.05
30.40 44.84
1.41 -1.29
1.32
-18.87 -17.80 -21.37 -29.58 -30.70
-8.06 -26.92 16.09 42.62 29.16
3.48
0.12 -3.87 11.75 -0.21
13.68 13.57 17.44
5.69
5.91
17.16
13.68
13.57
17.44
5.69
4.16
1.36
4.59
10.11
-0.16
0.01
5.18
1.13
0.46
6.77
-0.18
-0.15
5.33
1.07
2.94
9.34
-0.33
-0.07
3.45
0.52
-1.60
2.37
-0.71
-0.06
-0.35
9.61
6.44
8.94
1.60
-18.19 -16.58 -46.34 -11.78
0.39 12.44 41.42 16.95
-8.19
2.30
4.03
6.76
14.09 11.80
7.77
1.01
5.91
14.09
11.80
7.77
2.64
0.74
-0.78
2.60
-0.91
0.02
2.55
0.65
-3.23
-0.03
-0.88
-0.04
1.71
-4.50
3.66
0.86
0.15
0.07
-0.88
-0.81
1.81
0.12
0.03
1.01
0.15
er, Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or completeness of any Data in the AceEquity and is not responsible
ployees/ representatives does not accept any liability for any direct or consequential loss arising from the use of the Data contained in th
e AceEquity and is not responsible for any

he use of the Data contained in the AceEquity
Albert David Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item

18.46
14.52
-5.45
27.54
13.39
13.73
-2.45
24.66
11.24
12.62
-7.06
16.80
-6.76
-4.42
-5.93
16.41
12.51
3.64
32.56
-2.84
-5.16
20.78
-23.99
-2.06
-5.28
14.53
20.24
-9.13
-8.12
3.00
11.54
10.86
-12.40
-10.57
-12.10
23.64
24.56
-4.75
-11.21
8.59
15.05
9.26
14.53
11.54
23.64
Source:AceEquity
15.72
12.79
-3.15
25.36
-3.93
-4.49
12.18
13.03
4.40
29.62
-5.15
-3.98
11.93
10.47
-6.39
16.01
-3.63
-4.71
14.65
7.10
-13.31
8.44
-2.41
-2.38
11.87
4.26
2.73
18.86
-1.14
-3.63
6.63
4.39
-1.43
9.59
-1.37
-2.98
10.94
3.97
4.51
19.42
-1.33
-3.86
7.94
4.86
-1.77
11.03
-1.91
-2.54
5.94
4.89
0.27
11.10
-2.48
-2.71
4.00
4.77
1.02
9.79
-3.20
-0.56
1.52
6.76
-2.33
5.95
-3.95
-0.91
2.06
7.54
-2.29
7.30
-4.36
-0.30
16.94
-13.18
-4.93
-1.18
16.22
20.48
-8.61
-2.73
9.14
7.08
7.67
-24.41
18.80
2.06
5.03
3.65
-16.46
6.44
-6.36
11.39
14.09
-21.39
1.28
-6.03
17.42
5.24
-5.05
4.63
4.81
12.61
14.22
-2.72
-5.50
6.01
6.60
6.57
-2.27
-0.56
3.74
2.86
5.92
-3.40
-3.89
-1.37
4.23
6.03
-4.13
-0.57
1.32
2.91
1.09
-1.93
1.08
0.25
2.66
2.65
-1.05
-1.54
0.06
2.60
15.05
16.22
7.08
5.03
11.39
17.42
12.61
6.60
2.86
4.23
2.91
2.66
Mar-98
-1.74
8.92
0.83
8.00
-5.08
-0.05
2.88
-1.01
-1.97
-0.11
2.71
2.60

Aarey Drugs && Pharmaceuticals Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]
DESCRIPTION
Profit Before Tax
Adjustment
Interest Paid
Tax Paid
Extra & Other Item
1.34
1.60
-3.36
-0.42
0.90
1.37
1.10
3.37
0.41
1.34
-10.73
-8.98
1.00
0.64
-12.60
-10.97
-0.42
1.86
-1.10
0.34
0.51
3.37
-3.39
-0.61
-0.63
1.14
-8.98
-0.01
9.75
0.76
0.38
-10.97
-0.63
11.82
0.22
0.16
0.85
0.51
1.14
0.38
Source:AceEquity
completeness of any Data in the AceEquity and is not responsible for any errors or omissions or for the results obtained from
representatives does not accept any liability for any direct or consequential loss arising from the use of the Data contained in
Mar-10 Mar-09 Mar-08 Mar-07 Mar-06

0.95
0.47
-2.46
-1.04
0.91
0.46
-1.34
0.03
0.73
0.44
-0.96
0.22
1.01
0.48
-0.07
1.42
1.00
0.47
-2.40
-0.93
-1.18
-1.92
2.87
-0.23
0.40
0.03
-0.57
0.82
0.28
0.11
0.22
0.00
-0.22
0.00
0.12
1.42
-1.14
-0.20
0.09
0.03
-0.93
0.01
0.93
0.00
0.03
0.16
0.40
0.11
0.12
0.03
-0.14
or the results obtained from the use of such Data. Accord Fintech especially states that it has no financial liability whatsoever to the users
use of the Data contained in the AceEquity or any data generated from the AceEquity.
e. However, Accord Fintech Pvt Ltd does not guarantee the accuracy,adequacy or
al liability whatsoever to the users of AceEquity.Accord or any of its directors/ employees/

Pharma CF

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Pharma CF

Uploaded by

Copyright:

Available Formats

Zyden Gentec Ltd.

CashFlow - Standalone - Actual - Abridged- [INR-Crore]

eEquity and is not responsible for any errors

Venus Remedies Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

n the AceEquity and is not responsible for

Sun Pharmaceutical Industries Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

-2801.09 663.03 1725.83 1453.98

106.48 1339.18 1233.80

640.54 488.68 323.48 294.01 252.83 187.28 144.63

646.00 1262.49 626.13 450.56 310.81 219.81 329.95 160.73 150.08

977.31 1208.48 1230.98

Mar-98 Mar-97 Mar-96 Mar-95 Mar-94

Sandu Pharmaceuticals Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

eEquity and is not responsible for any errors

Pfizer Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

Mar-14 Mar-13 Mar-12 Mar-11

279.65 277.90 347.65

-123.94 -208.26 -121.81 -148.99

307.86 1432.92 866.26 578.42

527.40 543.02 479.79

ity and is not responsible for any errors or

Nutraplus India Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

eEquity and is not responsible for any errors

Novartis India Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

89.90 169.42 224.69 218.91

61.23 160.26 111.64

Mar-98 Mar-97 Mar-96

e AceEquity and is not responsible for any errors or omissions or for

Medicamen Biotech Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

eEquity and is not responsible for any errors

Jenburkt Pharmaceuticals Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

eEquity and is not responsible for any errors

JB Chemicals && Pharmaceuticals Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

93.99 107.74 809.22 141.05

-11.65 80.41 850.80 136.83

Mar-98 Mar-97 Mar-96

e AceEquity and is not responsible for any errors or omissions or for

Ipca Laboratories Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

527.08 386.85 318.84 214.57

193.52 154.92 110.31 113.25 123.85 61.68

Mar-98 Mar-97 Mar-96

AceEquity and is not responsible for any errors or omissions or for

Hester Biosciences Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

n the AceEquity and is not responsible for

Glenmark Pharmaceuticals Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

501.92 379.95 284.10 250.79

114.24 253.02 194.65 421.06

983.17 94.06 246.67

he AceEquity and is not responsible for any

Cadila Healthcare Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

531.40 670.40 637.20

129.40 104.50 118.30

the AceEquity and is not responsible for any

Biocon Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

Mar-14 Mar-13 Mar-12 Mar-11

185.80 348.00 160.50 354.70

Mar-10 Mar-09 Mar-08 Mar-07 Mar-06 Mar-05 Mar-04 Mar-03 Mar-02

230.73 115.99 264.86 116.81

BDH Industries Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

eEquity and is not responsible for any errors

Bafna Pharmaceuticals Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]

Mar-10 Mar-09 Mar-08 Mar-07 Mar-05 Mar-04

Astrazeneca Pharma India Ltd. CashFlow - Standalone - Actual - Abridged- [INR-Crore]